About 50 results
Open links in new tab
  1. How to Take Repatha® (evolocumab) Injection

    Find how to take Repatha® SureClick® Autoinjector, Pushtronex® System, and Prefilled Syringe through self-administration. See Full Prescribing & Safety Info.

  2. Advise the patient and/or caregiver to read the FDA-approved patient labeling [Patient Information and Instructions for Use (IFU)] before the patient starts using REPATHA, and each time the …

  3. How to Use Repatha® (evolocumab) SureClick Injection

    Watch a demonstration video to learn how to self-administer the Repatha® SureClick® Autoinjector. See Full Prescribing & Safety Info.

  4. INJECTION RESOURCES FOR YOU Are you getting started at home? Feel confident in knowing you have supplemental injection support online, on the phone, or at home.

  5. ® Autoinj Read all instructions in carton before use. Questions? Call 1-844-REPATHA (1-844-737-2842)

  6. Starting Repatha® (evolocumab) Treatment

    Be ready to dispose of the used device in a sharps disposal container. Repatha ® will remain good for use for up to 30 days if kept at room temperature (68°F to 77°F). We also have a step …

  7. Patient Resources and Support | Repatha® (evolocumab)

    Access helpful Repatha® resources to support you on your path to lowering your high bad (LDL) cholesterol. See Full Prescribing & Safety Info.

  8. The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and …

  9. Repatha® (evolocumab) Cost and Co-Pay Card Information

    If you and your doctor have decided to start Repatha ®, understanding how to pay for your treatment is an important next step. We’re here to help you understand your insurance coverage.

  10. Amgen SupportPlus Dashboard - repatha.com

    Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are …